SGLT2 Inhibitors Market Analysis: Emerging Therapies and Forecast
The sglt2 inhibitors Market is evolving through pharmaceutical innovation and the expansion of SGLT2 inhibitor use across multiple chronic conditions. The global market is forecast to increase from USD 4.96 billion in 2024 to USD 15.0 billion by 2035, reflecting a 10.6% CAGR. Combination therapy is one of the major trends shaping the market. Pharmaceutical companies are exploring approaches...
0 Comments 0 Shares 28 Views 0 Reviews